Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Glipizide Patent Expiration

Glipizide is used for managing hyperglycemia in diabetes through oral administration of a once-a-day sustained release dosage form of Glipizide. It was first introduced by Pfizer Inc in its drug Glucotrol on May 8, 1984. Another drug containing Glipizide is Glucotrol Xl. 18 different companies have introduced drugs containing Glipizide.


Glipizide Patents

Given below is the list of patents protecting Glipizide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Glucotrol Xl USRE44459 Method for lowering blood glucose Mar 26, 2019

(Expired)

 Pfizer
Glucotrol Xl US5591454 Method for lowering blood glucose Jan 07, 2014

(Expired)

 Pfizer



Glipizide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Glipizide Generic API Manufacturers

Several generic applications have been filed for Glipizide. The first generic version for Glipizide was by Aurobindo Pharma Usa Inc and was approved on May 10, 1994. And the latest generic version is by Rubicon Research Private Ltd and was approved on Oct 3, 2023.

Given below is the list of companies who have filed for Glipizide generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

tablet Discontinued ORAL N/A Sep 11, 1997
5MG

tablet Discontinued ORAL N/A Sep 11, 1997





2. AIPING PHARM INC

Aiping Pharmaceutical Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Aiping Pharm Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

tablet Discontinued ORAL N/A Apr 7, 1995
5MG

tablet Discontinued ORAL N/A Apr 7, 1995





3. ANI PHARMS

Ani Pharmaceuticals Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Ani Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

tablet Discontinued ORAL N/A Mar 4, 1996
5MG

tablet Discontinued ORAL N/A Mar 4, 1996





4. APOTEX

Apotex Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Prescription ORAL AB Jun 13, 2001
10MG

(reference standard)

tablet Prescription ORAL AB Jun 13, 2001


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
North York Apotex Inc.
Brantford Apotex Pharmachem Inc.
Toronto Apotex Inc.
Richmond Hill Apotex Inc.
Etobicoke Apotex, Inc.
Winnipeg Apotex Fermentation Inc.
India
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bangalore Apotex Pharmachem India Pvt Ltd.
Bengaluru Apotex Research Private Limited





5. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet, extended release Prescription ORAL AB May 12, 2017
5MG

tablet, extended release Prescription ORAL AB May 12, 2017
10MG

tablet, extended release Prescription ORAL AB May 12, 2017


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd
Bachupally Aurobindo Pharma Limited
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Sangareddy Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





6. AUROBINDO PHARMA USA

Aurobindo Pharma Usa Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Prescription ORAL AB May 10, 1994
10MG

tablet Prescription ORAL AB May 10, 1994


Manufacturing Plant Locations
New

Aurobindo Pharma Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Usa as present at those locations.

Country City Firm Name
United States
East Windsor Aurobindo Pharma USA Inc





7. BARR LABS INC

Barr Laboratories Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Barr Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A Apr 4, 1997
10MG

tablet Discontinued ORAL N/A Apr 4, 1997





8. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A Jun 20, 1995
10MG

tablet Discontinued ORAL N/A Jun 20, 1995





9. ENDO OPERATIONS

Endo Operations Ltd has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet, extended release Discontinued ORAL N/A Sep 20, 2013
10MG

tablet, extended release Discontinued ORAL N/A Sep 20, 2013





10. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 3 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet, extended release Discontinued ORAL N/A May 19, 2015
10MG

tablet, extended release Discontinued ORAL N/A May 19, 2015
2.5MG

tablet, extended release Discontinued ORAL N/A May 19, 2015





11. OXFORD PHARMS

Oxford Pharmaceuticals Llc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Oxford Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

tablet Prescription ORAL AB Nov 28, 1994
5MG

tablet Prescription ORAL AB Nov 28, 1994





12. RUBICON

Rubicon Research Private Ltd has filed for 3 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Rubicon.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet Prescription ORAL N/A Oct 3, 2023
5MG

tablet Prescription ORAL AB Oct 3, 2023
10MG

tablet Prescription ORAL AB Oct 3, 2023


Manufacturing Plant Locations
New

Rubicon's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Rubicon as present at those locations.

Country City Firm Name
United States
Geismar Rubicon, LLC
Indianapolis Rubicon Foods LLC
Canada
Concord Rubicon Research Canada Limited
India
Ambarnath Rubicon Research Private Limited





13. SUN PHARM INDS INC

Sun Pharmaceutical Industries Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Discontinued ORAL N/A Jul 11, 2006
10MG

tablet Discontinued ORAL N/A Jul 11, 2006





14. UNIQUE

Unique Pharmaceutical Laboratories A Div Of Jb Chemicals And Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Unique.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet, extended release Prescription ORAL AB Dec 29, 2016
5MG

tablet, extended release Prescription ORAL AB Dec 29, 2016
10MG

(reference standard)

tablet, extended release Prescription ORAL AB Dec 29, 2016


Manufacturing Plant Locations
New

Unique's manufacturing plants are situated in 5 countries - United States, India, Canada, Portugal, Taiwan. Given below are the details of these plant locations as well as the firm names of Unique as present at those locations.

Country City Firm Name
United States
Garner Unique Food Company
Landing Unique Encapsulation Technology, LLC
Norman Unique Confections LLC
Cypress Unique Distributors, Inc. dba Florentino Ice Cream
Ottawa Uniquely Emu Products, Inc.
Gold Canyon Unique Ingredients LLC.
Nashville Unique Surgical Inc
Bisbee Unique Coffee, LLC
Cumberland Unique Soy Products International, LLC
Brownsville Unique Candies Llc
Bridgeport Unique Instruments, Inc.
Richmond Hill Unique Importer & Distributor Inc.
Everett Unique sushi
Concord Unique Molded Foam Technologies, Inc.
Chatsworth Unique Laboratories, Inc.
India
Sonepat Unique Fragrances
New Delhi Unique Fragrances
Navi Mumbai Unique Chemicals
Ankleshwar Unique Chemicals
Surat Unique Hospital- Multispecialty & Research Institute
Bharuch Unique Pharmaceutical Laboratories (A Division of J. B. Chemicals & Pharmaceuticals Ltd)
Canada
Cambridge Unique Global Product and Distribution Inc.
Portugal
Velas Uniqueijo - Uniao de Cooperativas Agricolas de Lacticinios de Sao Jorge, UCRL
Taiwan
Toucheng Township Unique Safety Equipment Co., Ltd





15. WATSON LABS

Watson Laboratories Inc has filed for 3 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet, extended release Prescription ORAL AB Sep 8, 2003
10MG

tablet, extended release Prescription ORAL AB Nov 7, 2003
2.5MG

tablet, extended release Prescription ORAL AB Mar 27, 2006





16. WATSON LABS TEVA

Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Watson Labs Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG

tablet Prescription ORAL AB Feb 27, 1995
5MG

tablet Prescription ORAL AB Feb 27, 1995





17. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Glipizide. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet, extended release Prescription ORAL AB Jul 16, 2018
5MG

tablet, extended release Prescription ORAL AB Jul 16, 2018
10MG

tablet, extended release Prescription ORAL AB Jul 16, 2018